Latest Breaking News On - Patients rates - Page 1 : comparemela.com

Discover the potential of SGLT2 inhibitors- a class of diabetes drugs, in mitigating kidney stones risk in diabetic patients.

United statesJulie paikDivision of pharmacoepidemiologyDivision of renal kidney medicine at brighamMass general brighamGlucose cotransporterNephrolithiasis riskPatients with typePatients ratesMassachusetts general hospitalDiabetes drugSglt2 inhibitorsKidney stonesType 2 diabetesChronic kidney disease